Business
Press Release Oct 12 2020
Cipla Limited has informed the Exchange regarding a press release dated October 12, 2020, titled "Avenue Therapeutics, Inc. receives complete response letter from the FDA for IV Tramadol".
About this update from Cipla Ltd
[{"type":"text","content":" Cipla Limited has informed the Exchange regarding a press release dated October 12, 2020, titled \"Avenue Therapeutics, Inc. receives complete response letter from the FDA for IV Tramadol\". View Attachment","length":333,"tagName":"div"}]